Alivus Life Sciences Limited (GLS)
Market Open
12 Aug, 22:00
MSE MSE Primary XNSE ₹
1,357. 90
-33.4
-2.4006%
₹
- Market Cap
- P/E Ratio
- Div Yield
3,086 Volume
- Eps
₹ 1,391.3
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | 12.22 |
| | | - | 10.58 |
| | | - | 9.88 |
| | | 10 | 11.14 |
| | | - | 7.75 |
| | | - | 9.08 |
| | | 10.4 | 7.97 |
| | | - | 9.67 |
| | | 11.8 | 9.69 |
GLS Earnings Reports FAQ
What is the earnings per share (EPS) for GLS?
EPS data for GLS is currently not available, as Alivus Life Sciences Limited has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 2 years, the earnings growth rate has been approximately 12.3%, reflecting the GLS's performance and MSE market conditions.
When is the next earnings release date?
Alivus Life Sciences Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alivus Life Sciences Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLS at this time, as Alivus Life Sciences Limited has no recent EPS data to calculate it.
